Prize-based contingency management for the treatment of substance abusers: A meta-analysis

Addiction

Volumn 109, Issue 9, 2014, Pages 1426-1436

  Benishek, Lois A ^a,b   Dugosh, Karen L ^a   Kirby, Kim C ^a,b   Matejkowski, Jason ^a,c   Clements, Nicolle T ^a,d   Seymour, Brittany L ^a   Festinger, David S ^a,b  

^a TREATMENT RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d SAINT JOSEPH S UNIVERSITY   (United States)

Author keywords

Contingency management; Incentives; Meta analysis; Prize based; Substance abuse treatment; Substance use disorder

Indexed keywords

AWARDS AND PRIZES; DRUG USE; HUMAN; META ANALYSIS; MOTIVATION; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

AWARDS AND PRIZES; DRUG USERS; HUMANS; MOTIVATION; SUBSTANCE-RELATED DISORDERS;

EID: 84927595156     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12589     Document Type: Review

References (72)

1. Bigelow G., Silverman K. Theoretical and empirical foundations of contingency management treatments for drug abuse. In: Higgins S. T., Silverman K., editors. Motivating Behavior Change among Illicit-Drug Abusers: Research on Contingency Management Interventions. Washington, DC: American Psychological Association; 1999, pp. 15-31.
2. Petry N. M., Stitzer M. L. Contingency Management: Using Motivational Incentives to Improve Drug Abuse Treatment. West Haven, CT: Yale University Psychotherapy Development Center; 2002.
3. Bigelow G. E., Stitzer M. L., Griffiths R. R., Liebson I. A. Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations. Addict Behav 1981; 6: 241-252.
4. Higgins S. T., Alessi S. M., Dantona R. L. Voucher-based incentives: a substance abuse treatment innovation. Addict Behav 2002; 27: 887-910.
5. Higgins S. T., Heil S. H., Lussier J. P. Clinical implications of reinforcement as a determinant of substance use disorders. Annu Rev Psychol 2004; 55: 431-461.
6. Stitzer M., Petry N. Contingency management for treatment of substance abuse. Annu Rev Clin Psychol 2006; 2: 411-434.
7. Dutra L., Stathopoulou G., Basden S. L., Leyro T. M., Powers M. B., Otto M. W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 179-187.
8. Griffith J. D., Rowan-Szal G. A., Roark R. R., Simpson D. D. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend 2000; 58: 55-66.
9. Lussier J. P., Heil S. H., Mongeon J. A., Badger G. J., Higgins S. T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006; 101: 192-203.
10. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006; 101: 1546-1560.
11. Schumacher J. E., Milby J. B., Wallace D., Meehan D. C., Kertesz S., Vuchinich R. etal. Meta-analysis of day treatment and contingency-management dismantling research: Birmingham Homeless Cocaine studies. J Consult Clin Psychol 2007; 75: 823-828.
12. Silverman K., Wong C. J., Higgins S. T., Brooner R. K., Montoya I. D., Contoreggi C. etal. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend 1996; 41: 157-165.
13. Henggeler S. W., Halliday-Boykins C. A., Cunningham P. B., Randall J., Shapiro S. B., Chapman J. E. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments. J Consult Clin Psychol 2006; 74: 42-54.
14. Barnett P. G., Sorenson J. L., Wong W., Haug N. A., Hall S. M. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend 2009; 100: 115-121.
15. Sorensen J. L., Haug N. A., Delucchi K. L., Gruber V., Kletter E., Batki S. L. etal. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend 2007; 88: 54-63.
16. Jones H. E., Haug N., Silverman K., Stitzer M., Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 2001; 61: 297-306.
17. Washio Y., Higgins S. T., Heil S. H., Badger G. J., Skelly J., Bernstein I. M. etal. Examining maternal weight gain during contingency-management treatment for smoking cessation among pregnant women. Drug Alcohol Depend 2011; 114: 73-76.
18. Mancino M. J., McGaugh J., Feldman Z., Poling J., Oliveto A. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis. Am J Addict 2010; 19: 169-177.
19. Petry N. M., Martin B., Cooney J. L., Kranzler H. R. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000; 68: 250-257.
20. Petry N. M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002; 70: 398-405.
21. Petry N. M., Martin B., Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005; 73: 354-359.
22. Petry N. M., Peirce J. M., Stitzer M. L., Blaine J., Roll J. M., Cohen A. etal. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005; 62: 1148-1156.
23. Peirce J. M., Petry N. M., Stitzer M. L., Blaine J., Kellogg S., Satterfield F. etal. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006; 63: 201-208.
24. Petry N. M., Alessi S. M., Marx J., Austin M., Tardif M. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J Consult Clin Psychol 2005; 73: 1005-1014.
25. Petry N. M., Barry D., Alessi S. M., Rounsaville B. J., Carroll K. M. A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol 2012; 80: 276-285.
26. Petry N. M., Tedford J., Austin M., Nich C., Carroll K. M., Rounsaville B. J. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction 2004; 99: 349-360.
27. Stitzer M. L., Petry N., Peirce J., Kirby K., Killeen T., Roll J. etal. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol 2007; 75: 805-811.
28. Alessi S. M., Petry N. M., Urso J. Contingency management promotes smoking reductions in residential substance abuse patients. J Appl Behav Anal 2008; 41: 617-622.
29. Ford J. D., Hawke J., Alessi S., Ledgerwood D., Petry N. Psychological trauma and PTSD symptoms as predictors of substance dependence treatment outcomes. Behav Res Ther 2007; 45: 2417-2431.
30. Rash C. J., Alessi S. M., Petry N. M. Contingency management is efficacious for cocaine abstinence with prior treatment attempts. Exp Clin Psychopharmacol 2008; 16: 547-554.
31. Weinstock J., Rash C. J., Petry N. M. Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen? Psychol Addict Behav 2010; 24: 282-291.
32. Petry N. M., Weinstock J., Alessi S. M. A randomized trial of contingency management delivered in the context of group counseling. J Consult Clin Psychol 2011; 79: 686-696.
33. Rash C. J., Olmstead T. A., Petry N. M. Income does not affect response to contingency management treatments among community substance abuse seekers. Drug Alcohol Depend 2009; 104: 249-253.
34. Barry D., Sullivan B., Petry N. M. Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic, and White methadone maintenance clients. Psychol Addict Behav 2009; 23: 168-174.
35. Petry N. M., Alessi S. M. Prize-based contingency management is efficacious in cocaine-abusing patients with and without recent gambling participation. J Subst Abuse Treat 2010; 39: 282-288.
36. Light R., Smith P. Accumulating evidence: procedures for resolving contradictions among different research studies. Harv Educ Rev 1971; 41: 429-471.
37. Nurius P. S., Yeaton W. H. Research synthesis reviews: an illustrated critique of 'hidden' judgments, choices, and compromises. Clin Psychol Rev 1987; 7: 695-714.
38. Cohen J. The earth is round (p < .05). Am Psychol 1994; 49: 997-1003.
39. Higgins J. P. T., Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: The Cochrane Collaborative and John Wiley & Sons; 2008.
40. Petry N. M., Alessi S. M., Hanson T., Sierra S. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. J Consult Clin Psychol 2007; 75: 983-991.
41. Petry N. M., Alessi S. M., Carroll K. M., Hanson T., MacKinnon S., Rounsaville B. etal. Contingency management treatments: reinforcing abstinence versus adherence with goal-related activities. J Consult Clin Psychol 2006; 74: 592-601.
42. Roll J. M., Petry N. M., Stitzer M. L., Brecht M. L., Peirce J. M., McCann M. J. etal. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006; 163: 1993-1999.
43. Ghitza U. E., Epstein D. H., Schmittner J., Vahabzadeh M., Lin J. L., Preston K. L. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol 2007; 75: 765-774.
44. Petry N. M., Weinstock J., Alessi S. M., Lewis M. W., Dieckhaus K. Group-based randomized trial of contingencies for health and abstinence in HIV patients. J Consult Clin Psychol 2010; 78: 89-97.
45. Hser Y. I., Li J. H., Jiang H. F., Zhang R. M., Du J., Zhang C. B. etal. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction 2011; 106: 1801-1809.
46. Tracy K., Babuscio T., Nich C., Kiluk B., Carroll K. M., Petry N. M. etal. Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse 2007; 33: 253-258.
47. Petry N. M., Alessi S. M., Ledgerwood D. M. Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depend 2012; 122: 86-92.
48. Killeen T. K., McRae-Clark A. L., Waldrop A. E., Upadhyaya H., Brady K. T. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs 2012; 25: 33-41.
49. McDonell M. G., Srebnik D., Angelo F., McPherson S., Lowe J. M., Sugar A. etal. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry 2013; 170: 94-101.
50. Furlan A. D., Pennick V., Bombardier C., van Tulder M. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009; 34: 1929-1941.
51. van Tulder M. W., Assendelft W. J. J., Koes B. W., Lex B., the Editorial Board of the Cochrane Collaboration Back Review Group. Method guidelines for systematic reviews in the Cochrane Collaborative Back Review Group for Spinal Disorders. Spine 1997; 22: 2323-2330.
52. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Publishers; 1988.
53. DeCoster J. Meta-analysis notes [internet]. [Place unknown] [Publisher unknown] 2009 [updated 31July 2009]. Available at: http://www.stat-help.com/notes.html (accessed 31 January 2013) (Archived at http://www.webcitation.org/6PQ3hLz8y on 8 May 2014).
54. Hedges L. V., Vevea J. L. Fixed- and random-effects models in meta-analysis. Psychol Methods 1998; 3: 486-504.
55. Lipsey M. W., Wilson D. B. Practical Meta-Analysis. Thousand Oaks, CA: Sage Publications; 2001.
56. Higgins J. P., Thompson G. S. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
57. Higgins J. P., Thompson S. G., Deeks J. J., Altman D. G. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
58. Sackett P. R., Harris M. M., Orr J. M. On seeking moderator variables in the meta-analysis of correlational data: a Monte Carlo investigation of statistical power and resistance to Type I error. J Appl Psychol 1986; 71: 302-310.
59. Rosenthal R. The 'file drawer problem' and tolerance for null results. Psychol Bull 1979; 86: 638-641.
60. Begg C. B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
61. National Institute on Drug Abuse. Principles of Drug Addiction: A Research-Based Guide, 3rd edn. Bethesda, MD: National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services; 2012 December, 78 pp. Report no.: 12-4180.
62. Stokes T. F., Baer D. M. An implicit technology of generalization. J Appl Behav Anal 1977; 10: 349-367.
63. Kirby K. C., Bickel W. K. Toward an explicit analysis of generalization: a stimulus control interpretation. Behav Anal 1988; 11: 115-129.
64. Klein D. A., Slaymaker V. J., Dugosh K. L., McKay J. R. Computerized continuing care support for alcohol and drug dependence: a preliminary analysis of usage and outcomes. J Subst Abuse Treat 2012; 42: 795-802.
65. McKay J. R. Continuing care research: what we have learned and where we are going. J Subst Abuse Treat 2009; 36: 131-145.
66. McKay J. R., Lynch K. G., Shepard D. S., Pettunati H. M. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry 2005; 62: 199-207.
67. Ehrman R. N., Robbins S. J., Cornish J. W. Comparing self-reported cocaine use with repeated urine tests in outpatient cocaine abusers. Exp Clin Psychopharmacol 1997; 5: 150-156.
68. Kim M. T., Hill M. N. Validity of self-report of illicit drug use in young hypersensitive urban African American males. Addict Behav 2003; 28: 795-802.
69. Lundy A., Gottheil E., McLellan A. T., Weinstein S. P., Sterling R. C., Serota R. D. Underreporting of cocaine use at post-treatment follow-up and the measurement of treatment effectiveness. J Nerv Ment Dis 1997; 185: 459-462.
70. Del Boca F. K., Darkes J. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 2003; 98: 1-12.
71. McLellan A. T., Lewis D. C., O'Brien C. P., Kleber H. D. Drug dependence, a chronic medical illness. JAMA 2000; 284: 1689-1695.
72. Saitz R., Larson M. J., LaBelle C., Richardson J., Samet J. H. The case for chronic disease management for addiction. J Addict Med 2008; 2: 55-65.